Skip to main content
Log in

Cefepime versus ceftazidime as empirical therapy for fever in neutropenic patients with haematological malignancies

  • Original Article
  • Published:
Indian Journal of Hematology and Blood Transfusion Aims and scope Submit manuscript

Abstract

An open randomized comparative study was conducted to evaluate the efficacy of Cefepime (2 gm iv. 8 hr.) vs. ceftazidime (2 gm iv. every 8 hr.) in empirical therapy of febrile neutropenic patients. A total of 40 eligible febrile episodes were randomized to be treated with study regimen. Twenty febrile episodes were treated with cefepime and 20 were treated with ceftazidime. The two groups were comparable in terms of age, sex, height, underlying neoplasm, number of pretherapy neutrophils, duration of neutropenia. The overall therapeutic success rate of cetepime group (60%) was comparable to that of ceftazidime group (55%). The results of this study suggest that cefepime is an effective and safe agent in empirical therapy of febrile episode in neutropenic patient and its efficacy is comparable with that of ceftazidime.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bergumans T, Scolier SP (2002) Myelosuppression and infective complications. In: Souhami RL, Tannok I, Hohznberger P, Horiot SC, editors. Oxford Textbook of oncology. 2nd edn. Oxford University Press Inc., New York; Vol. 1: pp. 575–89

    Google Scholar 

  2. Finberg R (2005) Infections in patients with cancer. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, editors. Harrison’s Principles of Internal Medicine. Vol.1, 16th edn. New York: McGraw Hill; p 489–496

    Google Scholar 

  3. Fu Der Wang, Cheng Y Liu, Hui Chi Hsu, Iyh Pyng Gau, Wing Keung Chan, Ming Li Haung (1999) A comparative study of Cefepime versus Ceftezadime as empirical therapy in febrile neutropenic patients. Chemotherapy 45:370–379

    Article  PubMed  CAS  Google Scholar 

  4. Jandula B, Martino R, Gurgi M, Manteiga R, Sierra J (2001) Treatment of febrile neutropenia with cefepime monotherapy. Chemotherapy 47:226–231

    Article  PubMed  CAS  Google Scholar 

  5. Kebudi R, Gorgun O, Ayan I, Gurler N, Akici F, Toreci K (2001) Randomized comparison of cefepime versus Ceftezadime monotherapy for fever and neutropenia in children with solid tumours. Med Pediatr Oncol 36(4):434–441

    Article  PubMed  CAS  Google Scholar 

  6. Cordonniek C, Herbrecht R, Pico JL (1997) Cefepime / Amikacin versus Ceftazidime / Amikacin as empirical therapy for febrile episodes in neutropenic patients. A comparative study. The French Cefepime Study Group. Gun lnf Dis 24:41–51

    Google Scholar 

  7. Chandrasekhar PH, Arrow PM Cefepime versus Ceftezadime as empirical therapy for fever in neutropenic patients with cancer. Annals of Pharmacotherapy 34(9):989–995

  8. Motalar J, Segura A, Bosch C, Galan A, Juano, Molins C et al (2002) Cefepime monotherapy as an empirical initial treatment of patients with febrile neutropenia. Med Oncol 19(3): 161–166

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ghalaut, P.S., Chaudhry, U., Ghalaut, V.S. et al. Cefepime versus ceftazidime as empirical therapy for fever in neutropenic patients with haematological malignancies. Indian J Hematol Blood Transfus 23, 104–106 (2007). https://doi.org/10.1007/s12288-008-0007-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12288-008-0007-x

Keywords

Navigation